Parasitology: Host cholesterol synthesis contributes to growth of intracellular Toxoplasma gondii in macrophages

DOI 機関リポジトリ Web Site Web Site 参考文献24件
  • NISHIKAWA Yoshifumi
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • IBRAHIM Hany M.
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine Zoology Department, Faculty of Science, Minufiya University
  • KAMEYAMA Kyohko
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • SHIGA Ikumi
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • HIASA Jun
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine
  • XUAN Xuenan
    National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine

書誌事項

タイトル別名
  • Host Cholesterol Synthesis Contributes to Growth of Intracellular Toxoplasma gondii in Macrophages

この論文をさがす

抄録

The intracellular protozoan Toxoplasma gondii lacks the ability to synthesize sterol and scavenges cholesterol from the low-density lipoprotein receptor (LDLR) pathway of its host to facilitate replication. Sterol biosynthesis inhibitors, however, have a demonstrated anti-Toxoplasma effect. In this study, we examined the host mevalonate pathway as a novel source of cholesterol for T. gondii and its effects on parasite growth in macrophages. Parasite growth did not significantly change in the absence of LDLR or when LDL was exogenously supplemented. Lovastatin and compactin, both inhibitors of hydroxymethylglutaryl-CoA (HMG-CoA) reductase in the mevalonate pathway, significantly inhibited T. gondii growth in both wild-type and LDLR-knockout macrophages. Parasite growth was also suppressed by squalestatin, an inhibitor of squalene synthase, despite mevalonate producing isoprenoid intermediates in host cells. The present study demonstrates that lovastatin, compactin and squalestatin have anti-Toxoplasma activities and that the host cholesterol synthesis may contribute to parasite growth in macrophages.<br>

収録刊行物

参考文献 (24)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ